- Procter & Gamble Co (NYSE:PG) reported second-quarter FY22 sales growth of 6.12% year-on-year, to $20.95 billion, beating the analyst consensus of $20.34 billion.
- Organic sales increased 6%, driven by a 3% increase in shipment volume, a 3% increase in pricing to help offset the significant commodity and other input cost increases.
- Sales in the beauty segment rose 3%, the Grooming segment expanded 4%, and Health Care jumped 8%.
- Adjusted EPS of $1.66 beat the analyst consensus of $1.65.
- Gross profit decreased 2% Y/Y to $10.3 billion. The reported gross margin decreased by 400 basis points to 49.1%.
- The operating margin contracted 250 basis points to 24.7%, while operating income for the quarter fell 4% to $5.2 billion.
- P&G held $11.54 billion in cash and equivalents as of December 31, 2021.
- "We delivered very strong top-line growth and made sequential progress on earnings in the face of significant cost headwinds," said CEO Jon Moeller.
- Outlook: P&G raised FY22 all-in sales growth outlook to 3% - 4% (previously 2% - 4%).
- The company continues to expect FY22 core EPS growth of 3% - 6% versus FY21 Core EPS of $5.66.
- P&G also expects to pay over $8 billion in dividends and repurchase $9 billion - $10 billion of common shares in FY22.
- Price Action: PG shares are trading higher by 1.24% at $158.68 in premarket on the last check Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Gillette Maker Procter & Gamble Q2 Earnings Top Estimates
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks